Innovation Seminar Series: Metabolic and Infectious Disease

Registration is now closed. Please email alicia@onenucleus.com to be added to the waitlist

A joint One Nucleus and Cerba Research Innovation Seminar across two days focussing on exciting developments for therapeutics in two key research areas - metabolic disease and infectious disease.

Agenda

Day 1 Metabolic Disease

3:00 pm Welcome

3:10 pm Dr Pablo Ortiz, CSO, OWL Metabolomics
               Role of metabolomics in drug development of metabolic diseases

3:35 pm Dr Huw Davies, VP of Global Sales, Owlstone Medical
                Breath Biopsy® assessment of hepatic metabolism using volatile organic compounds 
                - Towards non-invasive diagnosis and monitoring of liver disease

4:00 pm Break

4:15 pm Dr David Blakey, CSO, MiNA Therapeutics
                Small activating RNAs - a novel therapeutic approach to upregulate target genes for  the treatment of metabolic disease

4:40 pm Dr Sarah Howell, CEO, Arecor
               Transforming diabetes care - using smart technology to deliver an artificial pancreas  system

5:05 pm Stuart Redding, COO, Medical Research Network
               Decentralised clinical trials - improving patient engagement and trial efficiency

 5:30 pm Close

Day 2 Infectious Disease

2:00 pm Welcome back

2:05 pm Becky Jones-Philips, Business Development Manager, Liverpool School of Tropical Medicine
               Delivering Integrated Solutions for Human Infections

2:30 pm Dr Benedicte Roquebert, Clinical Biologist, Cerba Healthcare & Dr Stephanie Haim Boukobza, Head of infectiology department, Cerba Healthcare 
              Challenges of Covid-19 testing- which test to use?

2:55 pm Break

3:10 pm Dimitar Tonev, Hepatology/Virology Consultant, Varia
                Investing against future pandemics
3:35 pm Dr Stephane Renard, Global Project Leader, Antibacterials, Evotec
                Delivering novel antibacterials to the clinic: bottlenecks and strategies

4:00 pm Close 

Following the end of the second day, all attendees will be invited to join an exciting #Coffeebuddies debate featuring an investor panel facilitated by Thought Leader Professor Tony Sedgwick.  This will be followed by a chance to network with the local life science community via Zoom breakout rooms.  The link to join will be provided during the innovation seminar session.